Dispensing requirements: Rx only

Argentine Industry

Each glass bottle with lyophilised injection contains zoledronic acid 4 mg, mannitol and sodium citrate.

Each glass bottle with dissolving solution contains water for injection.

DREICO is indicated for the treatment of malignant neoplastic hypercalcemia, and multiple myeloma and bone metastasis of solid tumours with conventional antineoplastic therapy.

Osteoclastic resorption inhibitor.

Keep at room temperature below 30º C in the marketed packing.

Packs containing 1 glass bottle with lyophilised injection + 1 glass bottle with dissolving solution.

Packs containing 25 glass bottles with lyophilised injection + 25 glass bottles with dissolving solution, 50 glass bottles with lyophilised injection + 50 glass bottles with dissolving solution, and 100 glass bottles with lyophilised injection + 100 glass bottles with dissolving solution, for use in hospitals.

Medicinal speciality authorised by the Ministry of Health.

Certificate Nº 54144